Meet DermAb.io

Meet DermAb.io, our new portfolio company, developing a clinical decision support tool for prescribing personalized biologic therapies for the treatment of chronic and autoimmune diseases.

Using their non-invasive technology, they retrieve and analyze biomarkers painlessly from the skin’s surface, generating a treatment recommendation value to empower physicians to prescribe the most effective biological medication the first time.

This reduces today’s long and painful trial and error process, while saving time and costs. Learn more here >> https://lnkd.in/daKzyf2